DVAX Competitors & Alternatives

Compare Dynavax Technologies Corporation with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

DVAX

Main Stock
$15.50
Tradestie Score
55
Market Cap
$1.21B
Revenue Growth
0.2%
Analyst Upside
+41.9%

Top Competitors

44 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
ANIP ANI Pharmaceuticals, Inc.
$80.06
$2.01B 20.3 55 Compare
LQDA Liquidia Corporation Common Stock
$83.85
$1.90B 494.8 56 Compare
TLRY Tilray Brands, Inc. Common Stock
$4.64
$1.84B - 54 Compare
HROW Harrow, Inc. Common Stock
$39.09
$1.79B - 53 Compare
PAHC Phibro Animal Health Corporation Class A
$37.15
$1.65B 15.6 48 Compare
BCRX BioCryst Pharmaceuticals Inc
$8.81
$1.55B - 49 Compare
AMLX Amylyx Pharmaceuticals, Inc. Common Stock
$20.17
$1.49B - 60 Compare
AVDL Avadel Pharmaceuticals plc Ordinary Share
$21.64
$1.46B - 62 Compare
EVO Evotec SE American Depositary Shares
$1.94
$1.34B - 48 Compare
XERS Xeris Biopharma Holdings, Inc. Common Stock
$8.13
$1.29B 115.4 60 Compare

Data updated: Aug 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

44 stocks in this industry